DENTSPLY SIRONA (NASDAQ:XRAY) Director Buys $392,383.20 in Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory Lucier bought 27,555 shares of the stock in a transaction on Monday, March 2nd. The stock was purchased at an average price of $14.24 per share, for a total transaction of $392,383.20. Following the purchase, the director directly owned 27,555 shares of the company’s stock, valued at approximately $392,383.20. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

DENTSPLY SIRONA Stock Down 0.8%

XRAY opened at $13.33 on Friday. The company has a market capitalization of $2.66 billion, a PE ratio of -4.44, a price-to-earnings-growth ratio of 1.57 and a beta of 0.97. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.51 and a quick ratio of 1.03. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $17.18. The business has a 50-day moving average of $12.61 and a 200-day moving average of $12.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). The firm had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.26 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.8%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -21.33%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Eurizon Capital SGR S.p.A. acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at $26,000. Parkside Financial Bank & Trust boosted its holdings in DENTSPLY SIRONA by 620.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares during the period. Huntington National Bank boosted its holdings in DENTSPLY SIRONA by 292.9% in the 3rd quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 2,077 shares during the period. Finally, Caitong International Asset Management Co. Ltd grew its position in DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,122 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on XRAY shares. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and increased their target price for the stock from $13.00 to $17.00 in a research report on Thursday, February 19th. Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a report on Thursday, November 6th. Robert W. Baird raised their price objective on DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research note on Friday, February 27th. JPMorgan Chase & Co. decreased their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, November 7th. Finally, Wells Fargo & Company increased their price target on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Three analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $14.42.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.